These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20675978)

  • 1. Efficacy and tolerability of cyclobenzaprine extended release for acute muscle spasm: a pooled analysis.
    Weil AJ; Ruoff GE; Nalamachu S; Altman CA; Xie F; Taylor DR
    Postgrad Med; 2010 Jul; 122(4):158-69. PubMed ID: 20675978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclobenzaprine ER for muscle spasm associated with low back and neck pain: two randomized, double-blind, placebo-controlled studies of identical design.
    Malanga GA; Ruoff GE; Weil AJ; Altman CA; Xie F; Borenstein DG
    Curr Med Res Opin; 2009 May; 25(5):1179-96. PubMed ID: 19323613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose cyclobenzaprine versus combination therapy with ibuprofen for acute neck or back pain with muscle spasm: a randomized trial.
    Childers MK; Borenstein D; Brown RL; Gershon S; Hale ME; Petri M; Wan GJ; Laudadio C; Harrison DD
    Curr Med Res Opin; 2005 Sep; 21(9):1485-93. PubMed ID: 16197668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: a randomized, double-blind, two-period crossover study in healthy volunteers.
    Darwish M; Chang S; Hellriegel ET
    Clin Ther; 2009 Jan; 31(1):108-14. PubMed ID: 19243711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a low-dose regimen of cyclobenzaprine hydrochloride in acute skeletal muscle spasm: results of two placebo-controlled trials.
    Borenstein DG; Korn S
    Clin Ther; 2003 Apr; 25(4):1056-73. PubMed ID: 12809957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steady-state pharmacokinetics of once-daily cyclobenzaprine extended release: a randomized, double-blind, 2-period crossover study in healthy volunteers.
    Darwish M; Hellriegel ET
    Clin Ther; 2011 Jun; 33(6):746-53. PubMed ID: 21704239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic profile of once-daily cyclobenzaprine extended-release.
    Darwish M; Hellriegel ET
    Expert Opin Drug Metab Toxicol; 2010 Nov; 6(11):1425-36. PubMed ID: 20883117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, double-blind trial of carisoprodol 250 mg compared with placebo and carisoprodol 350 mg for the treatment of low back spasm.
    Serfer GT; Wheeler WJ; Sacks HJ
    Curr Med Res Opin; 2010 Jan; 26(1):91-9. PubMed ID: 19908948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to recovery in patients with acute painful musculoskeletal conditions treated with extended-release or immediate-release cyclobenzaprine.
    Landy S; Altman CA; Xie F
    Adv Ther; 2011 Apr; 28(4):295-303. PubMed ID: 21424735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose pharmacokinetics of once-daily cyclobenzaprine extended release 30 mg versus cyclobenzaprine immediate release 10 mg three times daily in healthy young adults : a randomized, open-label, two-period crossover, single-centre study.
    Darwish M; Hellriegel ET; Xie F
    Clin Drug Investig; 2008; 28(12):793-801. PubMed ID: 18991473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the single-dose pharmacokinetics of once-daily cyclobenzaprine extended-release 30 mg and cyclobenzaprine immediate-release 10 mg three times daily in the elderly: a randomized, open-label, crossover study.
    Darwish M; Xie F
    Drugs Aging; 2009; 26(2):95-101. PubMed ID: 19220066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclobenzaprine with ibuprofen versus ibuprofen alone in acute myofascial strain: a randomized, double-blind clinical trial.
    Turturro MA; Frater CR; D'Amico FJ
    Ann Emerg Med; 2003 Jun; 41(6):818-26. PubMed ID: 12764337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended-release cyclobenzaprine (Amrix).
    Med Lett Drugs Ther; 2007 Dec; 49(1276):102-3. PubMed ID: 18084153
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study.
    Malonne H; Coffiner M; Sonet B; Sereno A; Vanderbist F
    Clin Ther; 2004 Nov; 26(11):1774-82. PubMed ID: 15639689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclobenzaprine and naproxen versus naproxen alone in the treatment of acute low back pain and muscle spasm.
    Borenstein DG; Lacks S; Wiesel SW
    Clin Ther; 1990; 12(2):125-31. PubMed ID: 2141299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diclofenac potassium liquid-filled soft gelatin capsules in the management of patients with postbunionectomy pain: a Phase III, multicenter, randomized, double-blind, placebo-controlled study conducted over 5 days.
    Riff DS; Duckor S; Gottlieb I; Diamond E; Soulier S; Raymond G; Boesing SE
    Clin Ther; 2009 Oct; 31(10):2072-85. PubMed ID: 19922878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC; Fiske K; Lyne A
    Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclobenzaprine in the treatment of acute muscle spasm: review of a decade of clinical experience.
    Katz WA; Dube J
    Clin Ther; 1988; 10(2):216-28. PubMed ID: 3078905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.